基蛋生物
(603387)
| 流通市值：41.33亿 | | | 总市值：41.33亿 |
| 流通股本：5.07亿 | | | 总股本：5.07亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 568,870,540.13 | 474,266,178.51 | 418,393,722.67 | 484,332,524.77 |
| 应收票据及应收账款 | 408,174,653.24 | 425,146,736.76 | 452,677,616.38 | 445,425,859.12 |
| 其中：应收票据 | - | - | - | 600,000 |
| 应收账款 | 408,174,653.24 | 425,146,736.76 | 452,677,616.38 | 444,825,859.12 |
| 应收款项融资 | 1,210,000 | 300,000 | 766,000 | 4,603,410.8 |
| 预付款项 | 26,033,384.65 | 30,285,254.78 | 29,384,426.32 | 22,716,636.79 |
| 其他应收款合计 | 27,307,788.31 | 27,178,058 | 30,439,404.06 | 28,579,026.46 |
| 应收股利 | 2,358,319.44 | 2,358,319.44 | 2,358,319.44 | 2,358,319.44 |
| 存货 | 224,584,187.87 | 225,999,049.48 | 226,548,082.98 | 229,705,438.86 |
| 一年内到期的非流动资产 | 167,832,920.63 | 124,047,409.17 | 313,985,824.36 | 337,284,266.32 |
| 其他流动资产 | 9,185,356.53 | 17,337,954.35 | 30,577,995.96 | 146,629,076.41 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,035,564,467.08 | 1,844,692,386.28 | 2,021,269,147.48 | 2,151,184,140.66 |
| 非流动资产: | | | | |
| 长期应收款 | 5,213,260.03 | 6,353,986.75 | 7,550,341.63 | 8,227,913.74 |
| 长期股权投资 | 49,920,490.04 | 50,154,489.27 | 50,351,108.18 | 50,873,981.61 |
| 其他权益工具投资 | 38,500,000 | 78,500,000 | 71,000,000 | 71,000,000 |
| 其他非流动金融资产 | 91,817,222.75 | 91,752,152.88 | 91,951,271.26 | 94,025,722.18 |
| 固定资产 | 467,222,528.78 | 470,343,318.5 | 478,530,093.16 | 488,468,219.45 |
| 在建工程 | 263,981,146.62 | 255,729,565.83 | 235,484,378.82 | 205,761,114.67 |
| 使用权资产 | 6,998,838.22 | 7,822,599.39 | 8,736,284.68 | 9,629,281.05 |
| 无形资产 | 142,761,409.06 | 145,835,257.44 | 111,605,054.13 | 113,786,980.5 |
| 开发支出 | 42,070,283.69 | 40,674,009.32 | 72,694,231.65 | 68,148,928.86 |
| 商誉 | 26,135,621.88 | 26,135,621.88 | 26,135,621.88 | 26,135,621.88 |
| 长期待摊费用 | 10,323,898.18 | 11,457,558.26 | 12,466,915.72 | 11,968,949.98 |
| 递延所得税资产 | 46,426,552.62 | 45,097,805.87 | 42,932,185.86 | 43,179,451.18 |
| 其他非流动资产 | 707,823,324.63 | 744,870,058.92 | 557,444,452.82 | 429,235,747.18 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,899,194,576.5 | 1,974,726,424.31 | 1,766,881,939.79 | 1,620,441,912.28 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,934,759,043.58 | 3,819,418,810.59 | 3,788,151,087.27 | 3,771,626,052.94 |
| 流动负债: | | | | |
| 短期借款 | 650,379,287.4 | 627,400,646.67 | 631,118,510 | 641,287,084.95 |
| 交易性金融负债 | 132,957.52 | 46,584.36 | 624,051 | 583,273 |
| 应付票据及应付账款 | 142,943,634.98 | 141,328,302.22 | 131,894,068.49 | 129,075,017.5 |
| 其中：应付票据 | - | - | - | 85,500 |
| 应付账款 | 142,943,634.98 | 141,328,302.22 | 131,894,068.49 | 128,989,517.5 |
| 合同负债 | 51,478,793.55 | 39,350,212.92 | 35,152,547.1 | 38,168,205.41 |
| 应付职工薪酬 | 63,115,261.05 | 52,164,897.87 | 40,989,042.29 | 72,173,770.12 |
| 应交税费 | 26,575,080.9 | 17,262,423.98 | 18,766,391.69 | 23,355,120.67 |
| 其他应付款合计 | 41,781,179.46 | 41,971,573.18 | 38,231,742.2 | 45,179,666.29 |
| 一年内到期的非流动负债 | 9,690,347.7 | 9,700,972.75 | 9,311,543.73 | 22,676,578.53 |
| 其他流动负债 | 85,720,598.68 | 84,226,178.17 | 5,803,276.4 | 5,358,012.97 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,071,817,141.24 | 1,013,451,792.12 | 911,891,172.9 | 977,856,729.44 |
| 非流动负债: | | | | |
| 长期借款 | 50,000,000 | - | - | - |
| 租赁负债 | 3,281,777.53 | 3,126,482.86 | 3,823,261.77 | 2,713,207.61 |
| 预计负债 | 1,524,520.06 | 1,524,520.06 | 1,524,520.06 | 1,523,006 |
| 递延收益 | 18,943,064.76 | 19,589,180.7 | 20,235,296.64 | 20,881,412.58 |
| 递延所得税负债 | 23,389,715.1 | 23,765,494.06 | 26,143,304.14 | 27,405,253.19 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 97,139,077.45 | 48,005,677.68 | 51,726,382.61 | 52,522,879.38 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,168,956,218.69 | 1,061,457,469.8 | 963,617,555.51 | 1,030,379,608.82 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 507,153,517 | 507,153,517 | 507,153,517 | 507,153,517 |
| 资本公积 | 236,181,628.12 | 236,181,628.12 | 314,012,037.88 | 314,012,037.88 |
| 其他综合收益 | 775,339.61 | 1,063,066.79 | 942,920.94 | 928,007.07 |
| 专项储备 | 8,047,308.66 | 5,595,138.35 | 5,677,208.74 | 4,941,910.92 |
| 盈余公积 | 224,287,927.79 | 224,287,927.79 | 224,287,927.79 | 224,287,927.79 |
| 未分配利润 | 1,619,827,013.83 | 1,604,093,553.2 | 1,594,013,469.64 | 1,508,000,016.03 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,596,272,735.01 | 2,578,374,831.25 | 2,646,087,081.99 | 2,559,323,416.69 |
| 少数股东权益 | 169,530,089.88 | 179,586,509.54 | 178,446,449.77 | 181,923,027.43 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,765,802,824.89 | 2,757,961,340.79 | 2,824,533,531.76 | 2,741,246,444.12 |
| 负债和股东权益合计 | 3,934,759,043.58 | 3,819,418,810.59 | 3,788,151,087.27 | 3,771,626,052.94 |
| 公告日期 | 2024-10-31 | 2024-08-31 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 带强调事项段的无保留意见 |